Form strategy to stop using Mixopathy: IMA President urges Govt

Published On 2023-01-06 12:04 GMT   |   Update On 2023-01-06 12:04 GMT
Advertisement

The newly elected National President of the Indian Medical Association (IMA), Dr Sharad Kumar Agarwal, a renowned physician of Delhi/NCR, has urged the government to form a strategy to stop using Mixopathy, mixing of different medical disciplines.

He has taken over as the IMA National President – 2022-23 in Prayagraj in the gracious presence of Dr Ketan Desai, Past President of the World Medical Association, MCI & IMA. While Mixopathy has been a talk for a while and the Government is planning to introduce Integrated medicine and treatment protocols by 2030, IMA has also urged the Government to understand the impact of Mixopathy and rethink its strategy.

Advertisement

For more details, check out the link given below:

Govt Needs To Rethink The Strategy Of Mixopathy: IMA President Dr Sharad Kumar Agarwal



Full View
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News